Fig. 6From: Deciphering the pharmacological mechanisms of Fraxini Cortex for ulcerative colitis treatment based on network pharmacology and in vivo studiesConformations of molecular docking for (A) Fraxetin with PTGS2, BÂ Beta-sitosterol with FOS, CÂ Ursolic acid with MAPK8, and DÂ Ursolic acid with MMP9Back to article page